↓ Skip to main content

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

Overview of attention for article published in Cancer Immunology, Immunotherapy, April 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#44 of 2,903)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

patent
69 patents
wikipedia
2 Wikipedia pages

Readers on

mendeley
104 Mendeley